Sino-Biocan (Shanghai) Biotech Ltd
PrivateLast Round
Series B
Mar 27, 2024
Total Funding Raised
$29.7M
Company Overview
Sino-Biocan (Shanghai) Biotech Ltd operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in March 2024.
Sino-Biocan (Shanghai) Biotech Ltd is a biotechnology company that develops and manufactures automated, modular, closed-system platforms for the production of cellular products used in medicine and biotechnology.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sino-Biocan (Shanghai) Biotech Ltd Comparables
Compare Sino-Biocan (Shanghai) Biotech Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. | 86% | |
| Ori Biotech | 85% | |
| Astraveus | 83% |
For institutional investors. Book with your work email.
Sino-Biocan (Shanghai) Biotech Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 27, 2024 | ||||
| Series A | Mar 1, 2022 | ||||
| Angel | Oct 6, 2021 |
For institutional investors. Book with your work email.
Sino-Biocan (Shanghai) Biotech Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sinovation Ventures | Angel, Series B, Series A |
| Neovision Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2024
Raised $14M with participation from Neovision Capital and Sinovation Ventures.
- Mar 1, 2022
$16M round led by Sinovation Ventures
For institutional investors. Book with your work email.
Sino-Biocan (Shanghai) Biotech Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sino-Biocan (Shanghai) Biotech Ltd's valuation, stock price, and market status.
Is Sino-Biocan (Shanghai) Biotech Ltd a public or private company?
Sino-Biocan (Shanghai) Biotech Ltd is a private company.
What is the current stock price of Sino-Biocan (Shanghai) Biotech Ltd?
Sino-Biocan (Shanghai) Biotech Ltd is a private company, so its shares have no public market price. Caplight tracks Sino-Biocan (Shanghai) Biotech Ltd's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sino-Biocan (Shanghai) Biotech Ltd worth (valuation)?
Valuation information for Sino-Biocan (Shanghai) Biotech Ltd is not publicly available.
Can I buy Sino-Biocan (Shanghai) Biotech Ltd stock?
Sino-Biocan (Shanghai) Biotech Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sino-Biocan (Shanghai) Biotech Ltd's last funding round?
Sino-Biocan (Shanghai) Biotech Ltd's most recent funding round was Series B on March 27, 2024.
Who are the main investors in Sino-Biocan (Shanghai) Biotech Ltd?
Key investors in Sino-Biocan (Shanghai) Biotech Ltd include Sinovation Ventures, Neovision Capital.
Will Sino-Biocan (Shanghai) Biotech Ltd IPO soon?
No public IPO plans have been announced for Sino-Biocan (Shanghai) Biotech Ltd.
How can I track Sino-Biocan (Shanghai) Biotech Ltd secondary market activity?
Caplight tracks bids, offers, and trades in Sino-Biocan (Shanghai) Biotech Ltd's shares on secondary markets.